Extracellular matrix degradation by metalloproteinases and central nervous system diseases

Molecular Neurobiology

Volumn 19, Issue 3, 1999, Pages 267-284

  Lukes, Anton ^a,b   Mun Bryce, Sheila ^a   Lukes, Manuela ^a   Rosenberg, Gary A ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Blood brain barrier; Brain tumors; Cerebral ischemia; Extracellular matrix; Matrix metalloproteinases

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 4; COLLAGENASE; ELASTIN; ENTACTIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GELATIN; GELATINASE A; GELATINASE B; GLUCOCORTICOID; GLYCOPROTEIN; HEMOPEXIN; MATRILYSIN; MATRIX METALLOPROTEINASE; NERVE GROWTH FACTOR; NEUTRAL PROTEINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN PRECURSOR; PROTEOGLYCAN; RETINOID; SOMATOMEDIN; STROMELYSIN; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VITRONECTIN;

ALZHEIMER DISEASE; BRAIN INFECTION; BRAIN ISCHEMIA; BRAIN TUMOR; CAPILLARY PERMEABILITY; CENTRAL NERVOUS SYSTEM DISEASE; DEGRADATION; DEMYELINATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GLIOSIS; GUILLAIN BARRE SYNDROME; MULTIPLE SCLEROSIS; PROTEIN DEGRADATION; REVIEW;

EID: 0032821995     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02821717     Document Type: Review

References (105)

1. Abe T., Mori T., Kohno K., Seiki M., Hayakawa, T., Welgus H. G., et al. (1994) Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin. Exp. Metastasis 12, 296-304.
2. Agarwall C., Hembree J. R., Rorke E. A., and Eckert R. L. (1994) Transforming growth factor β1 regulation of metalloproteinase production in cultured human cervical epithelial cells. Cancer res. 54, 943-949.
3. Anthony D. C., Ferguson B., Matyzak M. K., Miller K. M., Esiri M. M., and Perry V. H. (1997) Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol. Appl. Neurobiol. 23, 406-415.
4. Armao D., Kornfeld M., Estrada E. Y., Grossetete M., and Rosenberg G. A. (1997) Neutral proteases and disruption of the blood-brain barrier in rat. Brain Res. 767, 259-264.
5. Backstrom J. R., Miller C. A., and Tokes Z. A. (1992) Characterisation of neutral proteinases from Alzheimer-affected and control brain specimen: identification of calcium-dependent metalloproteinases from the hippocampus. J. Neurochem. 58, 983-992.
6. Barger S. W. and Harmon A. D. (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein. Nature 388, 878-882.
7. Belayev L., Busto R., Zhao W., and Ginsberg M. D. (1996) Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 739, 88-96.
8. Benbow U. and Brinckerhoff C. E. (1997) The AP-1 site and MMP gene regulation: What is all the fuss about? Matrix Biol. 15, 519-526.
9. Bernstein J. J. and Karp S. M. (1996) Migrating fetal astrocytes do not intravasate since they are excluded from blood vessels by vital basement membrane. Int. J. Dev. Neurosci. 14, 177-180.
10. Bignami A., Leblanc A., and Perides G. (1994) A role for extracellular matrix degradation in senile dementia? Acta Neuropathol. 87, 308-312.
11. Birkedal-Hansen H. (1993) Role of cytokines and inflammatory mediators in tissue destruction. J. Periodont. Res. 28, 500-510.
12. Black P. M., Carroll R., Glowacka D., Riley, K., and Dashner K. (1994) Platelet-derived growth factor expression and stimulation in human meningiomas. J. Neurosurg. 81, 388-393.
13. Brenner D. A., O'Hara M., Angel P., Chojkier M., and Karin M. (1989) Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature 337, 661-663.
14. Brooks P. C., Montgomery A. M. P., Rosenfeld M., Reisfeld R. A., Hu T., Klier G., et al. (1994) Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
15. Brooks P. C., Stroemblad S., Klemke R., Visscher D., Sarkar F. H., and Cheresh D. A. (1995) Anti-Integrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96, 1815-1822.
16. Brooks P. C., Stroemblad S., Sanders L. C., von Schalscha T. L., Aimes R. T., Stetler-Stevenson W. G., et al. (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 85, 683-693.
17. Brosnan C. F., Cammer W., Norton W. T., and Bloom B. R. (1980) Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis. Nature 285, 235-237.
18. Cammer W., Bloom B. R., Norton W. T., and Gordon S. (1978) Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelinisation. Proc. Natl. Acad. Sci. USA 75, 1554-1558.
19. Chicoine M. R., Madsen C. L., and Silbergeld D. L. (1995) Modification of human glioma locomotion in vitro by cytokines EGF, bFGF, PDGFbb, NGF, and TNFα. Neurosurgery 36, 1165-1171.
20. Chintala S. K., Gokaslan Z. L., Go Y., Sawaya R., Nicolson G. L., and Rao J. S. (1996) Role of extracellular matrix proteins in regulation of human glioma cell invasion in vitro. Clin. Exp. Metastasis 14, 358-366.
21. Clark A. W., Krekoski C. A., Bou S.-S., Chapman K. R., and Edwards D. R. (1997) Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci. Lett. 238, 53-56.
22. Clark E. A. and Brugge J. S. (1995) Integrins and signal transduction pathways: The road taken. Science 268, 233-239.
23. Clubb B. H. and Shivers R. R. (1996) Extracellular matrix regulates microfilaments and vinculin organization in C6 glioma cells. Acta Neuropathol. 91, 31-40.
24. Colton C. A., Keri J. E., Chen W. T., and Monsky W. L. (1993) Protease production by cultured microglia: substrate gel analysis and immobilized matrix degradation. J. Neurosci. Res. 35, 297-304.
25. Crawford H. C. and Matrisian L. M. (1996) Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells [Review] [105 refs]. Enzyme Protein 49, 20-37.
26. Deb S. and Gottschall P. E. (1996) Increased production of matrix Metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with β-amyloid peptides. J. Neurochem. 66, 1641-1647.
27. Delany A. M. and Brinckerhoff C. E. (1992) Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. J. Cell. Biochems. 50, 400-410.
28. Del Bigio M. R., Yan H., Buist R., and Peeling, J. (1996) Experimental intracerebral hemorrhage in rats. Magnetic resonance imaging and histopathological correlates. Stroke 27, 2312-2320.
29. Del Maestro R. F., Lopez-Torres M., McDonald W. B., Stroude E. C., and Vaithilingam I. S. (1992) The effect of tumor necrosis factor-α on human malignant glial cells. J. Neurosurg. 76, 652-659.
30. Edvardsen K., Chen W., Rucklidge G. J., Walsh F. S., Obrink B., and Bock E. (1993) Transmembrane neural cell-adhesion molecule (NCAM), but not glycosyl-phosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metalloproteinases. Proc. Natl. Acad. Sci. USA 90, 11,463-11,467.
31. 1 integrins. Cancer Res. 56, 1939-1947.
32. Gately S., Tsanaclis A. M. C., Takano S., Klagsbrun M., and Brem S. (1995) Cells transfected with basic fibroblast growth factor gene fused to a signal sequence are invasive in vitro and in situ in the Brain. Neurosurgery 36, 780-788.
33. Giese A., Loo M. A., Rief M. D., Tran N., and Berens M. E. (1995) Substrates for astrocytoma invasion. Neurosurgery 37, 294-302.
34. Gijbels K., Masure S., Carton H., and Opdenakker G. (1992) Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J. Neuroimmunol. 41, 29-34.
35. Gijbels K., Proost P., Masure S., Carton H., Billiau A., and Opdenakker G. (1993) Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves nyelin basic protein. J. Neurosci. Res. 36, 432-440.
36. Gijbels K., Galardy R. E., and Steinman, L. (1994) Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94, 2177-2182.
37. Gladson C. L. (1996) Expression of integrin αVβ3 in small blood vessels in glioblastoma tumors. J. Neuropathol Exp. Neurol. 55, 1143-1149.
38. Gottschall P. E. (1995) Cytokines regulates gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J. Neurochem. 64, 1524-1535.
39. Haines D. E., Harkley L., and Al-Mefty, O. (1993) The "subdural" space: a new look at an outdated concept. Neurosurgery 32, 111-120.
40. Hughes P. M., Wells G. M., Clements J. M., Gearing A. J., Redford E. J., Davies M., et al. (1998) Matrix metalloproteinase expression during experimental autoimmune neuritis. Brain 121, 481-494.
41. Imren S., Kohn D. B., Shimada H., Blavier L., and De Clerck Y. A. (1996) Overexpression of tissue inhibitor of metalloproteinase-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res. 56, 2891-2895.
42. Jonat C., Rahmsdorf H. J., Park K. K., Cato A. C., Gebel S., Ponta H., et al. (1990) Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62, 1189-1204.
43. Kalaria R. N. (1992) The blood-brain barrier and cerebral microcirculation in Alzheimer disease. Cerebrovasc. Brain Metab. Rev. 4, 226-260.
44. Kawamata H., Kameyama S., Nan L., and Oyasu R. (1993) Effect of epidermal growth factor and transforming growth factor β1 on growth and invasive potentials of newly established rat bladder carcinoma cell lines. Int. J. Cancer 55, 968-973.
45. Kieseier B. C., Clements J. M., Pischel H. B., Wells G. M., Miller K., Gearing A. J., et al. (1998a) Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barre syndrome. Ann. Neurol. 43, 427-434.
46. Kieseier B. C., Kiefer R., Clements J. M., Miller K., Wells G. M., Schweitzer T., et al. (1998b) Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis. Brain 121, 159-166.
47. Lee S. C., Liu W., Dickson D. W., Brosnan C. F., and Berman J. W. (1997) Cytokine production by human fetal microglia and astrocytes. J. Immunol. 150, 2659-2667.
48. Leibowitz S. and Kennedy L. (1972) Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis. Immunology 22, 859-869.
49. Leppert D., Waubant E., Galardy R., Bunnett N. W., and Hauser S. L. (1995) T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol. 154, 4379-4389.
50. Liesi P., Kaakkola S., Dahl D., and Vaheri, A. (1984) Laminin is induced in astrocytes of adult brain by injury. EMBO J. 3, 68-686.
51. Lim G. P., Russell M. J., Cullen M. J., and Tokes Z. A. (1997) Matrix metalloproteinases in dog brains exhibiting Alzheimer-like characteristics. J. Neurochem. 68, 1606-1611.
52. Mahesparan R., Tysnes B. B., Edvardsen K., Haugeland H. K., Cabrera I. G., Lund-Johansen M., et al. (1997) Role of high molecular weight extracellular matrix proteins in glioma cell migration. Neuropathol. Appl. Neurobiol. 23, 102-112.
53. Matsuzawa K., Fukuyama K., Hubbard S. L., Dirks P. B., and Rutka J. T. (1996) Transfection of an invasive human astrocytoma cell line with a TIMP-1 cDNA: modulation of astrocytoma invasive potential. J. Neuropathol. Exp. Neurol. 55, 88-96.
54. Mazzieri R., Masiero L., Zanetta L., Monea S., Onisto M., Garbisa S., et al. (1997) Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J. 16, 2319-2332.
55. Miyazaki K., Umenishi F., Funahashi K., Koshikawa N., Yasumitsu H., and Umeda M. (1992) Activation of TIMP-2/progelatinase A complex by stromelysin. Biochem. Biophys. Res. Commun. 185, 852-859.
56. Miyazaki K., Hasegawa M., Funahashi K., and Umeda M. (1993) A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature 362, 839-841.
57. Mohanam S., Wang S. W., Rayford A., Yamamoto M., Sawaya R., Nakajima M., et al. (1995) Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo. Clin. Exp. Metastasis 13, 57-62.
58. Muir D. (1994) Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix Is induced by nerve growth factor. Exp. Cell Res. 210, 243-252.
59. Muir D., Johnson J., Rojiani M., Inglis B. A., Rojiani A., and Maria B. L. (1996) Assessment of laminin-mediated glioma invasion in vitro and by glioma tumor engrafted within rat spinal cord. J. Neurooncol. 30, 199-211.
60. Muller M., Hubbard S. L., Fukuyama K., Dirks P., Matsuzakawa K., and Rutka J. T. (1995) Characterization of a pineal region malignant rhabdoid tumor towards understanding brain tumor cell invasion. Pediatr. Neurosurg. 22, 204-209.
61. Mun-Bryce S. and Rosenberg G. A. (1998) Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am. J. Physiol. 274, R1203-R1211.
62. Nagano N., Sasaki H., Aoyagi M., and Hirakawa K. (1993) Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol. 86, 117-125.
63. Nagase H. (1997) Activation mechanism of matrix metalloproteinases. Biol. Chem. 378, 151-160.
64. Nakagawa T., Kubota T., Kabuto M., Sato K., Kawano H., Hayakawa T., et al. (1994) Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J. Neurosurg. 81, 69-77.
65. Nakano A., Tani E., Miyazaki K., Yamamoto Y., and Furuyama J. (1995a) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J. Neurosurg. 83, 298-307.
66. Nakano A., Tani E., Yamamoto Y., Furuyama J., and Miyazuki K. (1995b) Increased expression of gelatinases A and B, matrilysin and T1MP-1 genes in human malignant gliomas. Nippon Rinsho 53, 1816-1821.
67. Okumura Y., Sato H., Seiki M., and Kido, H. (1997) Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator. FEBS Lett. 402, 181-184.
68. Olson J. J., Reisner A., Klemm J. M., and Bakay R. A. E. (1993) Basic fibroblastic growth factor as a potential meningeal angiogenic factor. Skull Base Surg. 3, 117-122.
69. Paterson P. Y. (1976) Experimental allergic encephalomyelitis: role of fibrin deposition in immunopathogenesis of inflammation. Fed. Proc. 35, 2428-2434.
70. Pedersen P. H., Marienhagen K., Mork S., and Bjerkvig R. (1993) Migratory patterns of fetal rat brain cells and human glioma cells in the adult rat brain. Cancer Res. 53, 5158-5165.
71. Pedersen P. H., Edvardsen K., Garcia-Cabrera I., Mahesparan R., Thorsen J., Mathisen B., et al. (1995) Migratory patterns of lac-z transfected human glioma cells in the rat brain. Int. J. Cancer 62, 767-771.
72. Peress N., Perillo E., and Zucker S. (1995) Localization of tissue inhibitor of matrix metalloproteinases in Alzheimer's disease and normal brain. J. Neuropathol. Exp. Neurol. 54, 16-22.
73. Perris K. (1997) The extracellular matrix in neural crest-cell migration. Trends Neurosci. 20, 23-31.
74. 3. J. Biol. Chem. 272, 2736-2743.
75. Powell W. C. and Matrisian L. M. (1996) Complex roles of matrix metalloproteinases in tumor progression. Curr. Top. Microbiol. Immunol. 213(PE1), 1-21.
76. Previtali S., Quattrini A., Nemni K., Truci G., Ducati A., Wrabetz L., et al. (1996) α6β4 and α6β1 integrins in astrocytomas and other CNS tumors. J. Neuropathol Exp. Neurol 55, 456-465.
77. Redekop G. J. and Naus, C. C. G. (1995) Transfection with bFGF sense and antisense cDNA resulting in modification of malignant glioma growth. J. Neurosurg. 82, 83-90.
78. Redford E. J., Smith K. J., Gregson N. A., Davies M., Hughes P., Gearing A. J., et al. (1997) A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis. Brain 120, 1895-1905.
79. Romanic A. M. and Madri J. A. (1994) Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol. 4, 145-156.
80. Rosenberg G. A. (1995) Matrix metalloproteinases in brain injury. J. Neurotrauma 12, 151-155.
81. Rosenberg G, A. and Navratil M. (1997) Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48, 921-926.
82. Rosenberg G. A., Mun-Bryce S., Wesley M., and Kornfeld M. (1990) Collagenase-induced intracerebral hemorrhage in rats. Stroke 21, 801-807.
83. Rosenberg G. A., Kornfeld M., Estrada E., Kelley R. O., Liotta L. A., and Stetler-Stevenson, W. G. (1992) TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res. 576, 203-207.
84. Rosenberg G. A., Estrada E. Y., Dencoff J. E., and Stetler-Stevenson W. G. (1995) Tumor necrosis factor-alpha-induced gelatinase-B causes delayed opening of the blood-brain barrier. An expanded therapeutic window. Brain Res. 703, 151-155.
85. Rosenberg G. A., Dencoff J. E., Correa N., Reiners M., and Ford C. C. (1996) Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: Relation to blood-brain barrier injury. Neurology 46, 1626-1632.
86. Rosenberg G. A., Dencoff J. E., and Estrada E. Y. (1998) Matrix metalloproteinases and TIMPs modulate blood-brain barrier opening after reperfusion in rat brain. Stroke, 29, 2189-2195.
87. Ruoslahti E. (1997) Stretching is good for a cell. Science 276, 1345,1346.
88. Rutka J. T., Apodaca G., Stern R., and Rosenblum M. L. (1988) The extracellular matrix of the central and peripheral nervous system: structure and function. J. Neurosurg. 69, 155-170.
89. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., et al. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61-65.
90. Sato H., Kinoshita T., Takino T., Nakayama K., and Seiki M. (1996) Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett. 393, 101-104.
91. Sawada M., Kondo N., Suzumura A., and Marunouchi T. (1989) Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 491, 394-397.
92. Sawaya R., Tofilon P. J., Mohanam S., Ali-Osman F., Liotta L. A., Stetler-Stevenson, W. G., et al. (1994) Induction of tissue-type plasminogen activator and 72-kDa type IV collagenase by ionizing radiation in rat astrocytes. Int. J. Cancer 56, 214-218.
93. Schnaper H. W., Grant D. S., Stetler-Stevenson W. G., Fridman R., D'Orazi G., Murphy A. N., et al. (1993) Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell. Physiol. 156, 235-246.
94. Seiki M. (1996) Membrane type-matrix metalloproteinase and tumor invasion. Curr. Top. Microbiol. Immunol. 213(Pt 1), 23-32.
95. Strongin Y. A., Marmer B. L., Grant G. A., and Goldberg G. I. (1993) Plasma-membrane dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem. 268, 14,033-14,039.
96. Tawil N., Wilson P., and Carbonetto S. (1993) Integrins in point contacts mediate cell spreading: Factors that regulate Integrin accumulation in in point contacts vs focal contacts. J. Cell. Biol. 120, 261-271.
97. Tomasek J. J., Halliday N. L., Updike D. L., Ahern-Moore J. S., Vu T. H., Liu R. W., et al. (1997) Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J. Biol. Chem. 272, 7482-7487.
98. Turpeenniemi-Hujanen T., Thorgeirsson U. P., Rao C. N., and Liotta L. A. (1986) Laminin increases the release of type IV collagenase from malignant cells. J. Biol. Chem. 261, 1883-1889.
99. Vlodavsky I., Ishai-Michaeli R., Atzmon R., Mohsen M., Levi E., Bar-Shavit R., et al. (1992) Extracellular sequestration and release of fibroblast growth factor: A possible mechanism for indirect angiogenesis, in Growth Factors of the Vascular and Nervous System. International Symposium on Biotechnology of Growth Factors, Milan, May 1991 (Lenfant C., Paoletti R., and Albertini A., eds.), Karger, Basel, pp. 38-47.
100. Wagner S., Tagaya M., Koziol J. A., Quaranta V., and del Zoppo J. (1997) Rapid disruption of an astrocyte interaction with the extracellular matrix mediated by integrin α6β4 during focal cerebral ischemia/reperfusion. Stroke 28, 858-865.
101. Weiner H. L. (1995) The role of growth factor receptors in central nervous system development and neoplasia. Neurosurgery 37, 179-194.
102. Wells G. M. A., Catlin G., Cossins J. A., Mangan M., Ward G. A., Miller K. M., et al. (1996) Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard. Glia 18, 332-340.
103. Yamada T., Yoshiyama Y., Sato H., Seiki M., Shingawa A., and Takahashi M. (1995) White matter microglia produce membrane-type matrix metalloproteinase, an activator of gelatinase A, in human brain tissues. Acta Neuropathol. 90, 421-424.
104. Yang G. and Betz A. L. (1994) Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 25, 1658-1665.
105. Yong V. W., Kerkoski C. A., Forsyth P. A., Bell R., and Edwards D. R. (1998) Matrix metalloproteinases and diseases of the CNSs. Trends Neurosci. 21, 75-80.